|
| 华东医药(000963)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-11-17 | 159.91 | 0.09% | 175414.38 | 11.87 | 175109.65 | 99.82% | 股权激励限售股份 | | 2025-09-29 | 19.25 | 0.01% | 175254.47 | 171.78 | 175090.40 | 99.81% | 股权激励限售股份 | | 2024-10-28 | 19.25 | 0.01% | 175109.65 | 316.61 | 175090.40 | 99.81% | 股权激励限售股份 | | 2023-12-05 | 122.09 | 0.07% | 175094.80 | 347.74 | 174972.70 | 99.73% | 股权激励限售股份 | | 2019-02-11 | 15599.47 | 10.70% | 145817.46 | 0.00 | 145817.46 | 100.00% | 增发A股原股东配售上市 | | 2014-09-30 | 15410.74 | 35.50% | 43406.00 | 0.00 | 43406.00 | 100.00% | 股权分置限售流通 | | 2010-09-02 | 3352.67 | 7.72% | 27995.26 | 15410.74 | 43406.00 | 100.00% | 股权分置限售流通 | | 2009-01-06 | 2170.30 | 5.00% | 24642.58 | 18763.42 | 43406.00 | 100.00% | 股权分置限售流通 | | 2007-11-06 | 4430.86 | 10.21% | 22472.28 | 20933.72 | 43406.00 | 100.00% | 股权分置限售流通 |
|